[0JBU] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
27-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -16.63%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 52,121 33,053 57,994 43,103 30,434 26,117 16,479 21.14%
PBT -474,186 -267,892 -134,231 -99,533 -85,343 -67,543 -31,634 56.99%
Tax 16,022 -8,174 0 -6,835 0 0 0 -
NP -474,186 -267,892 -134,231 -99,533 -85,343 -67,543 -31,634 56.99%
Tax Rate - - - - - - - -
Total Cost 526,307 300,945 192,225 142,636 115,777 93,660 48,113 48.96%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -909.78 -810.49 -231.46 -230.92 -280.42 -258.62 -191.97 29.58%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -6.16 -3.78 -2.40 -1.96 -1.98 -1.88 -0.91 37.51%
EPS Diluted -6.16 -3.78 -2.40 -1.96 -1.98 -1.88 -0.91 37.51%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.